Magnus Financial Group’s BioAtla BCAB Stock Holding History

Magnus Financial Group’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-400	Closed	-$3.22K	–	395
2026 Q1	$3.22K	Hold	400	–	–	﹤0.01%	372
2025 Q4	$11.4K	Sell	400 -545	-58%	-$21.4K	﹤0.01%	416
2025 Q3	$32.5K	Hold	945	–	–	﹤0.01%	398
2025 Q2	$18.7K	Hold	945	–	–	﹤0.01%	379
2025 Q1	$16.4K	Hold	945	–	–	﹤0.01%	364
2024 Q4	$27.9K	Buy	+945	New	+$79.3K	﹤0.01%	359

Magnus Financial Group's BCAB Position: Q2 2026 in Review

Magnus Financial Group sold out of BioAtla (BCAB) in Q2 2026, closing a stake of 400 shares — an estimated $3.22K sold.

Magnus Financial Group first reported a position in BCAB in Q4 2024 and held it in 6 quarters. The position peaked at $32.5K in Q3 2025. 0 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

Magnus Financial Group reported no remaining BioAtla position as of Q2 2026 after selling out during the quarter.
Magnus Financial Group sold 400 BioAtla shares in Q2 2026, an estimated $3.22K.
Magnus Financial Group first reported a position in BioAtla in Q4 2024 and held it in 6 quarters.
Magnus Financial Group's BioAtla position peaked at $32.5K in Q3 2025.
0 funds tracked by Wall St. Rank held BioAtla as of Q2 2026.

Based on Magnus Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.